Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 9, 2025

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
ImmunologyAllergyGenetic DiseasesInfectious Diseases
Interventions
OTHER

blood sample

After signature of consent form,blood samples will be collected for full blood cell count;classical autoimmune investigations, immunophenotyping;auto-Abs against type IIFNs, other cytokines, or other target proteins ,Genetic explorations by whole-exome or whole-genome sequencing;Biobanking

Trial Locations (9)

Unknown

RECRUITING

Cic Lille, Lille

RECRUITING

LYON HCL, Lyon

RECRUITING

Cic Montpellier, Montpellier

RECRUITING

Cic Bichat, Paris

RECRUITING

Cic Creteil, Paris

RECRUITING

Cic La Salpetriere, Paris

RECRUITING

Cic Necker, Paris

RECRUITING

Cic St Louis, Paris

RECRUITING

Cic Tours, Tours

All Listed Sponsors
lead

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

NCT06762002 - Impaired Type I IFN Immunity Due to Autoantibodies or a Genetic Defect: a Prospective National Cohort | Biotech Hunter | Biotech Hunter